FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3018600921> ?p ?o ?g. }

• W3018600921 endingPage "5416" @default.
• W3018600921 startingPage "5400" @default.
• W3018600921 abstract "Radiotherapy (RT) in practical use often suffers from off-target side effects and ineffectiveness against hypoxic tumor microenvironment (TME) as well as remote metastases. With regard to these problems, herein, we provide semiconductor heterojunction structured WO2.9-WSe2-PEG nanoparticles to realize a synergistic RT/photothermal therapy (PTT)/checkpoint blockade immunotherapy (CBT) for enhanced antitumor and antimetastatic effect. Based on the heterojunction structured nanoparticle with high Z element, the nanosystem could realize non-oxygen-dependent reactive oxygen species generation by catalyzing highly expressed H2O2 in TME upon X-ray irradiation, which could further induce immunogenic cell death. Meanwhile, this nanosystem could also induce hyperthermia upon near-infrared irradiation to enhance RT outcome. With the addition of anti-PD-L1 antibody-based CBT, our results give potent evidence that local RT/PTT upon mild temperature and low radiation dose could efficiently ablate local tumors and inhibit tumor metastasis as well as prevent tumor rechallenge. Our study provides not only one kind of radiosensitizer based on semiconductor nanoparticles but also a versatile nanoplatform for simultaneous triple-combined therapy (RT/PTT/CBT) for treating both local and metastasis tumors." @default.
• W3018600921 created "2020-05-01" @default.
• W3018600921 creator A5007951489 @default.
• W3018600921 creator A5012770174 @default.
• W3018600921 creator A5015799036 @default.
• W3018600921 creator A5037497070 @default.
• W3018600921 creator A5040686568 @default.
• W3018600921 creator A5054199475 @default.
• W3018600921 creator A5057852508 @default.
• W3018600921 creator A5058350031 @default.
• W3018600921 creator A5060005951 @default.
• W3018600921 creator A5063713968 @default.
• W3018600921 creator A5076155990 @default.
• W3018600921 creator A5081637066 @default.
• W3018600921 creator A5085132583 @default.
• W3018600921 date "2020-04-23" @default.
• W3018600921 modified "2023-10-16" @default.
• W3018600921 title "A Heterojunction Structured WO_2.9-WSe₂ Nanoradiosensitizer Increases Local Tumor Ablation and Checkpoint Blockade Immunotherapy upon Low Radiation Dose" @default.
• W3018600921 cites W1853417408 @default.
• W3018600921 cites W1868554855 @default.
• W3018600921 cites W1963635535 @default.
• W3018600921 cites W1978762833 @default.
• W3018600921 cites W1996830477 @default.
• W3018600921 cites W1998470098 @default.
• W3018600921 cites W2003601710 @default.
• W3018600921 cites W2016612145 @default.
• W3018600921 cites W2060070314 @default.
• W3018600921 cites W2075647502 @default.
• W3018600921 cites W2079206873 @default.
• W3018600921 cites W2080083059 @default.
• W3018600921 cites W2081559176 @default.
• W3018600921 cites W2118278569 @default.
• W3018600921 cites W2118471749 @default.
• W3018600921 cites W2156311525 @default.
• W3018600921 cites W2160613616 @default.
• W3018600921 cites W2198709783 @default.
• W3018600921 cites W2209394102 @default.
• W3018600921 cites W2261545566 @default.
• W3018600921 cites W2309569522 @default.
• W3018600921 cites W2342459795 @default.
• W3018600921 cites W2398986011 @default.
• W3018600921 cites W2402896695 @default.
• W3018600921 cites W2403481844 @default.
• W3018600921 cites W2491502780 @default.
• W3018600921 cites W2549648393 @default.
• W3018600921 cites W2557894763 @default.
• W3018600921 cites W2558284519 @default.
• W3018600921 cites W2566571640 @default.
• W3018600921 cites W2587143085 @default.
• W3018600921 cites W2603097129 @default.
• W3018600921 cites W2702751937 @default.
• W3018600921 cites W2726656449 @default.
• W3018600921 cites W2736251717 @default.
• W3018600921 cites W2740375571 @default.
• W3018600921 cites W2744078894 @default.
• W3018600921 cites W2760813780 @default.
• W3018600921 cites W2762602728 @default.
• W3018600921 cites W2768942971 @default.
• W3018600921 cites W2770810616 @default.
• W3018600921 cites W2781216841 @default.
• W3018600921 cites W2787300529 @default.
• W3018600921 cites W2801287827 @default.
• W3018600921 cites W2808570189 @default.
• W3018600921 cites W2884102832 @default.
• W3018600921 cites W2885430894 @default.
• W3018600921 cites W2889540803 @default.
• W3018600921 cites W2897602119 @default.
• W3018600921 cites W2901245890 @default.
• W3018600921 cites W2911487527 @default.
• W3018600921 cites W2914293180 @default.
• W3018600921 cites W2915788568 @default.
• W3018600921 cites W2921150193 @default.
• W3018600921 cites W2936108057 @default.
• W3018600921 cites W2955833565 @default.
• W3018600921 cites W2959036110 @default.
• W3018600921 cites W2968653790 @default.
• W3018600921 cites W4244109348 @default.
• W3018600921 doi "https://doi.org/10.1021/acsnano.9b08962" @default.
• W3018600921 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32324373" @default.
• W3018600921 hasPublicationYear "2020" @default.
• W3018600921 type Work @default.
• W3018600921 sameAs 3018600921 @default.
• W3018600921 citedByCount "94" @default.
• W3018600921 countsByYear W30186009212020 @default.
• W3018600921 countsByYear W30186009212021 @default.
• W3018600921 countsByYear W30186009212022 @default.
• W3018600921 countsByYear W30186009212023 @default.
• W3018600921 crossrefType "journal-article" @default.
• W3018600921 hasAuthorship W3018600921A5007951489 @default.
• W3018600921 hasAuthorship W3018600921A5012770174 @default.
• W3018600921 hasAuthorship W3018600921A5015799036 @default.
• W3018600921 hasAuthorship W3018600921A5037497070 @default.
• W3018600921 hasAuthorship W3018600921A5040686568 @default.
• W3018600921 hasAuthorship W3018600921A5054199475 @default.
• W3018600921 hasAuthorship W3018600921A5057852508 @default.
• W3018600921 hasAuthorship W3018600921A5058350031 @default.
• W3018600921 hasAuthorship W3018600921A5060005951 @default.
• W3018600921 hasAuthorship W3018600921A5063713968 @default.

• next